Literature DB >> 11684075

The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.

R M Bell1, D M Yellon.   

Abstract

Nitric oxide (NO) is implicated in triggering and mediating delayed preconditioning. However, the role of NO and endothelial nitric oxide synthase (eNOS) in early ischaemic preconditioning is controversial. To investigate the role of eNOS in this paradigm further, the response of hearts isolated from either eNOS knockout (KO) or eNOS wild type (WT) mice to various ischaemic-preconditioning stimuli were studied. To determine whether eNOS is pivotal to early ischaemic preconditioning, hearts from both groups were subjected to a robust ischaemic-preconditioning stimulus consisting of four cycles of 5 min ischaemia and reperfusion (4PC) prior to an injurious ischaemia/reperfusion insult. Both WT and KO animals demonstrated significant attenuation of infarct size from 34.91+/-2.14 to 21.32+/-2.53% and from 30.92+/-1.87 to 22.60+/-2.98%, respectively. Whilst eNOS/NO appears not to be pivotal to early ischaemic preconditioning, NO can nonetheless mediate protection in both WT and KO hearts, as the NO donor, S-nitroso N-acetyl penicillamine (2 microM), was seen to mimic preconditioning protection. Therefore, it appears that the targets for NO mediated protection exist in both WT and KO hearts. Reducing the number of preconditioning cycles from four to three to two continued to result in significant attenuation of infarct size in WT hearts (26.30+/-2.86 and 26.70+/-1.95%). However, early ischaemic preconditioning failed in the KO hearts with any preconditioning stimulus less robust than the four cycle protocol used in the initial experiments (3PC 32.51+/-3.04%, 2PC 28.64+/-2.55%). Therefore, whilst eNOS is not essential for robust early ischaemic preconditioning, NO can be shown to be cardioprotective in its own right, and, moreover, eNOS and thus nitric oxide synthesis may contribute to early ischaemic preconditioning by lowering the ischaemic threshold for protection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684075     DOI: 10.1016/s0008-6363(01)00394-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

1.  Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Authors:  Janet R Manning; Gregory Carpenter; Darius R Porter; Stacey L House; Daniel A Pietras; Thomas Doetschman; Jo el J Schultz
Journal:  Growth Factors       Date:  2012-02-06       Impact factor: 2.511

2.  Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.

Authors:  Sofia-Iris Bibli; Ioanna Andreadou; Athanasia Chatzianastasiou; Christos Tzimas; Despina Sanoudou; Evangelia Kranias; Peter Brouckaert; Ciro Coletta; Csaba Szabo; Dimitrios Th Kremastinos; Efstathios K Iliodromitis; Andreas Papapetropoulos
Journal:  Cardiovasc Res       Date:  2015-04-13       Impact factor: 10.787

Review 3.  eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Authors:  Rakesh C Kukreja; Lei Xi
Journal:  J Mol Cell Cardiol       Date:  2006-12-18       Impact factor: 5.000

4.  Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.

Authors:  Changjun Yang; M A Hassan Talukder; Saradhadevi Varadharaj; Murugesan Velayutham; Jay L Zweier
Journal:  Cardiovasc Res       Date:  2012-09-12       Impact factor: 10.787

5.  Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes.

Authors:  A Görbe; Z V Varga; J Pálóczi; S Rungarunlert; N Klincumhom; M K Pirity; R Madonna; T Eschenhagen; A Dinnyés; T Csont; P Ferdinandy
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

6.  Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.

Authors:  Zhi-Dong Ge; Irina A Ionova; Nikolina Vladic; Danijel Pravdic; Naoyuki Hirata; Jeannette Vásquez-Vivar; Phillip F Pratt; David C Warltier; Galen M Pieper; Judy R Kersten
Journal:  Cardiovasc Res       Date:  2011-03-21       Impact factor: 10.787

7.  Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse.

Authors:  Yiru Guo; Qianhong Li; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Jingyao Mu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2008-01-17       Impact factor: 5.000

8.  Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism.

Authors:  Weidong Gu; Franz Kehl; John G Krolikowski; Paul S Pagel; David C Warltier; Judy R Kersten
Journal:  Anesthesiology       Date:  2008-04       Impact factor: 7.892

9.  The opposite roles of nNOS in cardiac ischemia-reperfusion-induced injury and in ischemia preconditioning-induced cardioprotection in mice.

Authors:  Xiao-Mei Lu; Guo-Xing Zhang; Yan-Qiu Yu; Shoji Kimura; Akira Nishiyama; Hiroko Matsuyoshi; Juichiro Shimizu; Miyako Takaki
Journal:  J Physiol Sci       Date:  2009-03-04       Impact factor: 2.781

10.  Renin Angiotensin system as a regulator of cell volume. Implications to myocardial ischemia.

Authors:  Walmor C De Mello
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.